Assessments, Curriculum, and Digital Content
Startups commercializing medical devices, imaging tools, or sensor-based systems that require FDA review or operate within a regulated medical pathway. This category includes hardware-based devices, software-connected devices, point-of-care diagnostics, molecular or biological assays, imaging technologies, and any product that performs clinical measurement, detection, diagnosis, monitoring, or therapeutic support.
The value in this category resides in the device’s or diagnostic technology’s ability to perform regulated clinical functions—such as detection, measurement, imaging, monitoring, or therapeutic support—through specialized hardware, sensors, biological analysis, or clinically validated algorithms. Commercial value is driven by the product’s safety, accuracy, regulatory clearance, and validated clinical performance, rather than software delivery mechanisms or unregulated content.
Launch Term | Requirements |
|---|---|
| Equity | 5% equity at the founder’s round. Anti-dilution through series A or capital raise of $1 Million. |
| Annual License Payments | NA |
| Royalty (based on cumulative revenue) | 20% |
| Annual Minimum Royalty Payments until first commercial sale |
|
| Sublicense Revenue Share | 40% |
| Patent Expense Reimbursement | NA |
| Diligence Milestone | First commercial sale of licensed product in 2 years. |
Access startup tools, grants, incubators, and mentorship through the Venture Center.